Specialized Therapeutics

Specialised Therapeutics is a commercial-stage biopharmaceutical company founded in 2007, specializing in the licensing and commercialization of oncology and rare disease therapies in the Australasian and Southeast Asian markets. The company leverages deep regional expertise and a partnership-driven model, having established collaborations with 18 international biopharma companies. With a track record of successfully launching multiple products and a significant philanthropic footprint, it has emerged as the largest independent pharmaceutical company in Australia. Its leadership team comprises seasoned executives from major global pharmaceutical firms.

Regional commercialization and market access platform for specialty pharmaceuticals, encompassing regulatory strategy, reimbursement navigation, full-service launch, and lifecycle management in Australia, New Zealand, and Southeast Asia.

Competes with other regional specialty pharma distributors, local affiliates of large multinational pharmaceutical companies, and potentially global licensing agencies. Its competitive edge lies in its deep, focused expertise in its specific regions, full-service commercialization capabilities, and established track record of successful product launches.